Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Martina, Penazzato"'
Autor:
Shrey Mathur, Melanie Smuk, Ceri Evans, Catherine J Wedderburn, Diana M Gibb, Martina Penazzato, Andrew J Prendergast
Publikováno v:
PLoS Medicine, Vol 21, Iss 2, p e1004334 (2024)
BackgroundWorld Health Organization (WHO) guidelines recommend cotrimoxazole prophylaxis for children who are HIV-exposed until infection is excluded and vertical transmission risk has ended. While cotrimoxazole has benefits for children with HIV, th
Externí odkaz:
https://doaj.org/article/d11e457bfdee45c0b96a270f0afa59cc
Autor:
Elisa Barbieri, Chiara Minotti, Sara Cavagnis, Carlo Giaquinto, Bernadette Cappello, Martina Penazzato, Marc Lallemant
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
The WHO Model List of Essential Medicines for Children (EMLc) has not been systematically revised in the last few years. We conducted a survey addressed to healthcare professionals prescribing, preparing, or administering medicines to children and a
Externí odkaz:
https://doaj.org/article/20a263b75ba44cb8913651a2f3f1eea0
Autor:
Catherine J. Wedderburn, Ceri Evans, Amy L. Slogrove, Andrea M. Rehman, Diana M. Gibb, Andrew J. Prendergast, Martina Penazzato
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 6, Pp n/a-n/a (2023)
Abstract Introduction Co‐trimoxazole prophylaxis is recommended for children born to women with HIV to protect those who acquire HIV from opportunistic infections, severe bacterial infections and malaria. With scale‐up of maternal antiretroviral
Externí odkaz:
https://doaj.org/article/67318f28bb22470da112579417d74a91
Autor:
Lisa Jane Frigati, Diana Gibb, Joseph Harwell, Judith Kose, Victor Musiime, Helena Rabie, Ajay Rangaraj, Pablo Rojo, Anna Turkova, Martina Penazzato
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 3, Pp n/a-n/a (2023)
Abstract Introduction Many children and adolescents living with HIV still present with severe immunosuppression with morbidity and mortality remaining high in those starting antiretroviral therapy (ART) when hospitalized. Discussion The major causes
Externí odkaz:
https://doaj.org/article/2f6df103af2149479cd56e6dff6e5b3b
Autor:
John O'Rourke, Claire L. Townsend, Edith Milanzi, Intira Jeannie Collins, Hannah Castro, Ali Judd, Marissa Vicari, Julie Jesson, Valériane Leroy, Martina Penazzato, Françoise Renaud
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 2, Pp n/a-n/a (2023)
Abstract Introduction Tenofovir alafenamide (TAF) is approved for paediatric use in fixed‐dose combination tablets, but efficacy and safety data in children are limited. We conducted a systematic review on the efficacy/effectiveness and safety of T
Externí odkaz:
https://doaj.org/article/506a2793526a41bba159fa5b9a5617fe
Autor:
Martina Penazzato, Ivy Kasirye, Theodore Ruel, Irene Mukui, Adrie Bekker, Mohendran Archary, Philippa Musoke, Shaffiq Essajee, George K. Siberry, Mary Mahy, Daniele Simnoue, Beatriz Simione, Jennifer M. Zech, Angela Mushavi, Elaine J. Abrams, PNP meeting participants
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 2, Pp n/a-n/a (2023)
Abstract Introduction Maternal antiretroviral therapy (ART) with viral suppression prior to conception, during pregnancy and throughout the breastfeeding period accompanied by infant postnatal prophylaxis (PNP) forms the foundation of current approac
Externí odkaz:
https://doaj.org/article/265f380308c5442dadaecc11c954ef8f
Autor:
Nicole C. McCann, Tijana Stanic, Martina Penazzato, Clare F. Flanagan, Elaine J. Abrams, Caitlin M. Dugdale, Leigh F. Johnson, Anne M. Neilan, Mary‐Ann Davies, Kenneth A. Freedberg, Patricia Fassinou, Meg Doherty, Shaffiq Essajee, Angela Mushavi, Djøra I. Soeteman, Andrea L. Ciaranello
Publikováno v:
Journal of the International AIDS Society, Vol 25, Iss 12, Pp n/a-n/a (2022)
Abstract Introduction To improve the diagnosis and survival of children living with HIV (CLWH), the World Health Organization recommends testing approaches beyond traditional infant HIV testing programmes. Information about undiagnosed HIV prevalence
Externí odkaz:
https://doaj.org/article/2c4e62e9ee9f4c6398d66be55b92cf3e
Autor:
Claire L. Townsend, John O'Rourke, Edith Milanzi, Intira Jeannie Collins, Ali Judd, Hannah Castro, Marissa Vicari, Julie Jesson, Valériane Leroy, Françoise Renaud, Martina Penazzato
Publikováno v:
Journal of the International AIDS Society, Vol 25, Iss 11, Pp n/a-n/a (2022)
Abstract Introduction Globally about 1.7 million children were living with HIV in 2020. Two integrase strand transfer inhibitors, dolutegravir and raltegravir, are increasingly used in children. We conducted a systematic review to assess the effectiv
Externí odkaz:
https://doaj.org/article/97ab22fa53bd4558b5894ef106f79983
Autor:
Laura Saint-Lary, Marc Harris Dassi Tchoupa Revegue, Julie Jesson, Françoise Renaud, Martina Penazzato, Claire L. Townsend, John O'Rourke, Valériane Leroy, WHO HIV Hepatitis and STIs (HHS) Department
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
BackgroundAtazanavir/ritonavir is recommended as a preferred second-line antiretroviral regimen in children older than 3 months, alternatively to lopinavir/ritonavir. We performed a systematic review to assess safety and effectiveness of atazanavir u
Externí odkaz:
https://doaj.org/article/18297fa7b565466eb628c43289b0646d
Autor:
Steve Kanters, Marco Vitoria, Michael Zoratti, Meg Doherty, Martina Penazzato, Ajay Rangaraj, Nathan Ford, Kristian Thorlund, Prof. Aslam H. Anis, Mohammad Ehsanul Karim, Lynne Mofenson, Rebecca Zash, Alexandra Calmy, Tamara Kredo, Nick Bansback
Publikováno v:
EClinicalMedicine, Vol 28, Iss , Pp 100573- (2020)
Background: To inform World Health Organization (WHO) global guidelines, we updated and expanded the evidence base to assess the comparative efficacy, tolerability, and safety of first-line antiretroviral therapy (ART) regimens. Methods: We searched
Externí odkaz:
https://doaj.org/article/08489ac96f464409bdd38a6663293e14